WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007082381) COMPOSITIONS CONTAINING (S)-BETHANECHOL AND THEIR USE IN THE TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES, GLUCOSE INTOLERANCE AND RELATED DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/082381    International Application No.:    PCT/CA2007/000075
Publication Date: 26.07.2007 International Filing Date: 19.01.2007
IPC:
A61K 31/27 (2006.01), A61K 31/198 (2006.01), A61K 31/385 (2006.01), A61K 45/06 (2006.01), A61P 3/10 (2006.01)
Applicants: DIAMEDICA INC. [CA/CA]; 4-1250 Waverley Street, Winnipeg, Manitoba R3T 6C6 (CA) (For All Designated States Except US).
WILLIAMS, Mark [CA/CA]; (CA) (For US Only)
Inventors: WILLIAMS, Mark; (CA)
Agent: RIDOUT & MAYBEE LLP; One Queen Street East, Suite 2400, Toronto, Ontario M5C 3B1 (CA)
Priority Data:
60/760,446 20.01.2006 US
Title (EN) COMPOSITIONS CONTAINING (S)-BETHANECHOL AND THEIR USE IN THE TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES, GLUCOSE INTOLERANCE AND RELATED DISORDERS
(FR) COMPOSITIONS CONTENANT (S)-BÉTHANÉCHOL ET LEUR UTILISATION POUR TRAITER LA RÉSISTANCE À L'INSULINE, LE DIABÈTE DE TYPE 2, L'INTOLÉRANCE AU GLUCOSE ET DES TROUBLES ASSOCIÉS
Abstract: front page image
(EN)The present invention provides pharmaceutical compositions comprising (S)-bethanechol or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable carrier and optionally at least one diabetes drug. The use of said composition in the treatment of insulin resistance, type 2 diabetes, impaired glucose tolerance and related disorders is also provided. The invention also provides for a kit comprising the pharmaceutical compositions and instructions for its use.
(FR)L'invention concerne des compositions pharmaceutiques comprenant du (S)-béthanéchol ou un sel de celui-ci, acceptable d'un point de vue pharmaceutique, un excipient acceptable d'un point de vue pharmaceutique, et éventuellement au moins un agent de traitement du diabète. L'invention concerne également l'utilisation de ladite composition dans le cadre du traitement de la résistance à l'insuline, du diabète de type 2, de la mauvaise tolérance au glucose et des troubles associés. L'invention a également pour objet un kit comprenant les compositions pharmaceutiques et des instructions relatives à leur utilisation.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)